Related Experiment Video
Updated: Jun 15, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Digenic mutations in severe congenital neutropenia
Manuela Germeshausen1, Cornelia Zeidler, Manfred Stuhrmann
1Department of Pediatric Hematology and Oncology/Molecular Hematopoiesis, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany. germeshausen.manuela@mh-hannover.de
Genetic digenicity may explain some cases of severe congenital neutropenia (SCN). This study identified novel mutations and suggests combined gene mutations contribute to this myelopoietic disorder.
Area of Science:
- Genetics
- Hematology
- Molecular Biology
Background:
- Severe congenital neutropenia (SCN) is a heterogeneous disorder with known monogenic causes like ELANE, HAX1, and G6PC3 mutations.
- Phenotypic variability within SCN subtypes suggests additional genetic or epigenetic factors influencing disease presentation.
Purpose of the Study:
- To investigate the potential role of digenicity in SCN.
- To identify novel mutations contributing to the complex genetic landscape of SCN.
Main Methods:
- Genetic analysis of SCN patients.
- Identification and characterization of mutations in candidate genes (ELANE, HAX1, G6PC3).
Main Results:
- Six novel mutations were identified in patients with SCN.
- Four patients presented with mutations in two candidate genes.
- Observed genotypes included heterozygous ELANE with homozygous G6PC3 or HAX1 mutations, and combined G6PC3/HAX1 mutations with heterozygous mutations in the other gene.
Conclusions:
- Digenicity, involving mutations in two genes, may underlie SCN in a subset of patients.
- These findings expand our understanding of the genetic basis of SCN and its heterogeneity.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations
Mutations in Microorganisms
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

